RHUMBLINE ADVISERS - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 189 filers reported holding ARRAY BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$14,691,000
+108.5%
317,104
+9.7%
0.03%
+100.0%
Q1 2019$7,045,000
+76.8%
288,951
+3.3%
0.01%
+55.6%
Q4 2018$3,985,000
+40.0%
279,658
+49.3%
0.01%
+80.0%
Q3 2018$2,846,000
-15.6%
187,256
-6.8%
0.01%
-28.6%
Q2 2018$3,372,000
+6.6%
200,956
+3.7%
0.01%0.0%
Q1 2018$3,162,000
+28.1%
193,778
+0.5%
0.01%
+40.0%
Q4 2017$2,468,000
-4.7%
192,811
-8.5%
0.01%
-16.7%
Q3 2017$2,591,000
+50.8%
210,685
+2.6%
0.01%
+50.0%
Q2 2017$1,718,000
-9.8%
205,265
-3.7%
0.00%0.0%
Q1 2017$1,905,000
+7.5%
213,082
+5.7%
0.00%0.0%
Q4 2016$1,772,000
+45.7%
201,582
+11.9%
0.00%
+33.3%
Q3 2016$1,216,000
+89.1%
180,210
-0.2%
0.00%
+50.0%
Q2 2016$643,000
+34.2%
180,610
+11.3%
0.00%
+100.0%
Q1 2016$479,000
-27.9%
162,207
+3.0%
0.00%
-50.0%
Q4 2015$664,000
+2.5%
157,427
+10.7%
0.00%0.0%
Q3 2015$648,000
-34.1%
142,192
+4.2%
0.00%
-33.3%
Q2 2015$984,000
-5.3%
136,508
-3.1%
0.00%0.0%
Q1 2015$1,039,000
+79.8%
140,923
+15.4%
0.00%
+50.0%
Q4 2014$578,000
+38.6%
122,098
+4.6%
0.00%
+100.0%
Q3 2014$417,000
-21.6%
116,7730.0%0.00%
-50.0%
Q2 2014$532,000
+8.4%
116,773
+11.8%
0.00%
+100.0%
Q1 2014$491,000
-10.4%
104,440
-4.6%
0.00%
-50.0%
Q4 2013$548,000
-19.5%
109,4600.0%0.00%0.0%
Q3 2013$681,000
+35.7%
109,460
-0.9%
0.00%0.0%
Q2 2013$502,000110,4950.00%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q2 2017
NameSharesValueWeighting ↓
Advisory Services Network, LLC 3,442$159,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ARRAY BIOPHARMA INC shareholders